Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea Syndrome
- Conditions
- Obstructive Sleep Apnea/Hypopnea Syndrome
- Registration Number
- NCT05491967
- Lead Sponsor
- Centre Hospitalier de Valence
- Brief Summary
a monocentric,non interventional, prospective study to compare cardiovascular risk in patients with Obstructive Sleep Apnea/Hypopnea Syndrome treated with Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Orthosis.
- Detailed Description
The first-line treatment of severe Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) is nocturnal ventilation with Continuous Positive Airway Pressure (CPAP). and The second-line treatment is the mandibular advancement orthosis (MAO)\].
CPAP is the most effective treatment to reduce the apnea-hypopnea index (AHI). However, its tolerance is sometimes difficult, causing many discontinuations.
The purpose of this review is to evaluate a vascular morbimortality criteria:
* Cardiovascular: myocardial infarction, heart failure, rhythm disorder
* Neurological: transient or non transient stroke
* ophthalmologic: anterior ischemic optic neuropathy, occlusion of the central artery or central retinal vein occlusion
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 172
- Obstructive Sleep Apnea/Hypopnea Syndrome treated with With Continuous Positive Airway Pressure (CPAP) or Mandibular Advancement Orthosis
- Age ≥ 18 years old
- Read, write and understand the French language
- Patient under guardianship, deprived of liberty, safeguard of justice
- Refusal to participate in research
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method morbimortality vascular criteria up to 6 months Presence or absence of ophthalmologic event
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ch Valence
🇫🇷Valence, Drome, France